BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

310 related articles for article (PubMed ID: 15240745)

  • 1. Urokinase-deficient and urokinase receptor-deficient mice have impaired neutrophil antimicrobial activation in vitro.
    Gyetko MR; Aizenberg D; Mayo-Bond L
    J Leukoc Biol; 2004 Sep; 76(3):648-56. PubMed ID: 15240745
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Urokinase receptor-deficient mice have impaired neutrophil recruitment in response to pulmonary Pseudomonas aeruginosa infection.
    Gyetko MR; Sud S; Kendall T; Fuller JA; Newstead MW; Standiford TJ
    J Immunol; 2000 Aug; 165(3):1513-9. PubMed ID: 10903758
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human urokinase-type plasminogen activator primes neutrophils for superoxide anion release. Possible roles of complement receptor type 3 and calcium.
    Cao D; Mizukami IF; Garni-Wagner BA; Kindzelskii AL; Todd RF; Boxer LA; Petty HR
    J Immunol; 1995 Feb; 154(4):1817-29. PubMed ID: 7836767
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Urokinase-type plasminogen activator receptor regulates leukocyte recruitment during experimental pneumococcal meningitis.
    Paul R; Winkler F; Bayerlein I; Popp B; Pfister HW; Koedel U
    J Infect Dis; 2005 Mar; 191(5):776-82. PubMed ID: 15688295
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Receptor-independent role of the urokinase-type plasminogen activator during arteriogenesis.
    Deindl E; Ziegelhöffer T; Kanse SM; Fernandez B; Neubauer E; Carmeliet P; Preissner KT; Schaper W
    FASEB J; 2003 Jun; 17(9):1174-6. PubMed ID: 12692088
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A urokinase-sensitive region of the human urokinase receptor is responsible for its chemotactic activity.
    Fazioli F; Resnati M; Sidenius N; Higashimoto Y; Appella E; Blasi F
    EMBO J; 1997 Dec; 16(24):7279-86. PubMed ID: 9405357
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mitogenic signaling of urokinase receptor-deficient kidney fibroblasts: actions of an alternative urokinase receptor and LDL receptor-related protein.
    Zhang G; Cai X; López-Guisa JM; Collins SJ; Eddy AA
    J Am Soc Nephrol; 2004 Aug; 15(8):2090-102. PubMed ID: 15284295
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Urokinase-type plasminogen activator receptor plays a role in neutrophil migration during lipopolysaccharide-induced peritoneal inflammation but not during Escherichia coli-induced peritonitis.
    Renckens R; Roelofs JJ; Florquin S; van der Poll T
    J Infect Dis; 2006 Feb; 193(4):522-30. PubMed ID: 16425131
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Urokinase receptor is necessary for adequate host defense against pneumococcal pneumonia.
    Rijneveld AW; Levi M; Florquin S; Speelman P; Carmeliet P; van Der Poll T
    J Immunol; 2002 Apr; 168(7):3507-11. PubMed ID: 11907112
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Urokinase plasminogen activator receptor promotes macrophage infiltration into the vascular wall of ApoE deficient mice.
    Gu JM; Johns A; Morser J; Dole WP; Greaves DR; Deng GG
    J Cell Physiol; 2005 Jul; 204(1):73-82. PubMed ID: 15573379
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential gene expression of urokinase-type plasminogen activator and its receptor in human renal cell carcinoma.
    Bhuvarahamurthy V; Schroeder J; Kristiansen G; Roigas J; Denkert C; Johannsen M; Lein M; Loening SA; Schnorr D; Jung K; Staack A
    Oncol Rep; 2005 Sep; 14(3):777-82. PubMed ID: 16077991
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clustering of urokinase receptors (uPAR; CD87) induces proinflammatory signaling in human polymorphonuclear neutrophils.
    Sitrin RG; Pan PM; Harper HA; Todd RF; Harsh DM; Blackwood RA
    J Immunol; 2000 Sep; 165(6):3341-9. PubMed ID: 10975852
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In situ gene expression of urokinase-type plasminogen activator and its receptor in transitional cell carcinoma of the human bladder.
    Bhuvarahamurthy V; Schroeder J; Denkert C; Kristiansen G; Schnorr D; Loening SA; Jung K; Staack A
    Oncol Rep; 2004 Oct; 12(4):909-13. PubMed ID: 15375521
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Urokinase-type plasminogen activator receptor reversibly dissociates from complement receptor type 3 (alpha M beta 2' CD11b/CD18) during neutrophil polarization.
    Kindzelskii AL; Laska ZO; Todd RF; Petty HR
    J Immunol; 1996 Jan; 156(1):297-309. PubMed ID: 8598477
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeting of urokinase plasminogen activator receptor in human pancreatic carcinoma cells inhibits c-Met- and insulin-like growth factor-I receptor-mediated migration and invasion and orthotopic tumor growth in mice.
    Bauer TW; Liu W; Fan F; Camp ER; Yang A; Somcio RJ; Bucana CD; Callahan J; Parry GC; Evans DB; Boyd DD; Mazar AP; Ellis LM
    Cancer Res; 2005 Sep; 65(17):7775-81. PubMed ID: 16140945
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Subcellular distribution of urokinase and urokinase receptor in human neutrophils determined by immunoelectron microscopy.
    Pedersen TL; Plesner T; Horn T; Høyer-Hansen G; Sørensen S; Hansen NE
    Ultrastruct Pathol; 2000; 24(3):175-82. PubMed ID: 10914429
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nonproteolytic role for the urokinase receptor in cellular migration in vivo.
    Waltz DA; Fujita RM; Yang X; Natkin L; Zhuo S; Gerard CJ; Rosenberg S; Chapman HA
    Am J Respir Cell Mol Biol; 2000 Mar; 22(3):316-22. PubMed ID: 10696068
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Urokinase plasminogen activator, uPa receptor, and its inhibitor in vernal keratoconjunctivitis.
    Leonardi A; Brun P; Sartori MT; Cortivo R; Dedominicis C; Saggiorato G; Abatangelo G; Secchi AG
    Invest Ophthalmol Vis Sci; 2005 Apr; 46(4):1364-70. PubMed ID: 15790903
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential localization and expression of urokinase plasminogen activator (uPA), its receptor (uPAR), and its inhibitor (PAI-1) mRNA and protein in endometrial tissue during the menstrual cycle.
    Nordengren J; Pilka R; Noskova V; Ehinger A; Domanski H; Andersson C; Høyer-Hansen G; Hansson SR; Casslén B
    Mol Hum Reprod; 2004 Sep; 10(9):655-63. PubMed ID: 15243126
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The C5a chemoattractant receptor mediates mucosal defence to infection.
    Höpken UE; Lu B; Gerard NP; Gerard C
    Nature; 1996 Sep; 383(6595):86-9. PubMed ID: 8779720
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.